4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-039564
Chief Business Development Off sold 417 shares at $47.42 ($19,774)
- Chief Business Development Off acquired 417 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BENZENO SHARON · Chief Business Development Off
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-26 | Exercise or conversion : show line 1 in the form | +417 | $6.32 | $2,635 | 417 | D |
| 2020-06-26 | Sale : show line 2 in the form | −417 | $47.42 | $19,774 | 0 | D |
| Open-market sales · 417 sh · avg $47.42 · $19,774 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-26 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −417 | 417 | D |
Loading xslF345X03/doc4.xml…